Literature DB >> 29728690

Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy.

Kwame Twumasi-Boateng1, Jessica L Pettigrew2, Y Y Eunice Kwok1, John C Bell3,4, Brad H Nelson5,6,7.   

Abstract

In the online html version of this article, the affiliations for Jessica L. Pettigrew and John C. Bell were not correct. Jessica L. Pettigrew is at the Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada and John C. Bell is at the Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. This is correct in the print and PDF versions of the article and has been corrected in the html version.

Entities:  

Year:  2018        PMID: 29728690     DOI: 10.1038/s41568-018-0019-2

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  5 in total

Review 1.  cGAS-STING, an important pathway in cancer immunotherapy.

Authors:  Minlin Jiang; Peixin Chen; Lei Wang; Wei Li; Bin Chen; Yu Liu; Hao Wang; Sha Zhao; Lingyun Ye; Yayi He; Caicun Zhou
Journal:  J Hematol Oncol       Date:  2020-06-22       Impact factor: 17.388

2.  Bibliometric analysis of oncolytic virus research, 2000 to 2018.

Authors:  Yidi Zou; Yong Luo; Jun Zhang; Ningshao Xia; Guowei Tan; Chenghao Huang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 3.  DNT Cell-based Immunotherapy: Progress and Applications.

Authors:  Yingrui Li; Kang Dong; Xueke Fan; Jun Xie; Miao Wang; Songtao Fu; Qin Li
Journal:  J Cancer       Date:  2020-03-31       Impact factor: 4.207

4.  Bluetongue Viruses Act as Novel Oncolytic Viruses to Effectively Inhibit Human Renal Cancer Cell Growth In Vitro and In Vivo.

Authors:  Haozhou Wang; Liming Song; Xin Zhang; Xiaodong Zhang; Xiaoguang Zhou
Journal:  Med Sci Monit       Date:  2021-01-28

Review 5.  Perspectives on Oncolytic Salmonella in Cancer Immunotherapy-A Promising Strategy.

Authors:  Ding Wang; Xiaodong Wei; Dhan V Kalvakolanu; Baofeng Guo; Ling Zhang
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.